FACULTY
David B. Brushwood, RPh, JD
Professor of Pharmaceutical Outcomes and Policy
The University of Florida
College of Pharmacy

FINANCIAL DISCLOSURE
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

David B. Brushwood, RPh, JD, reported no financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

The following planners and managers, Linda Graham, RN, BSN, BA, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN, Jan Schultz, RN, MSN, CCMEP, and Joseph Cupolo, MA, MS, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

ACCREDITATION STATEMENT
Pharmacy
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 430-000-09-005-H03-P; 430-000-09-005-H03-T
Credits: 2.0 hours (0.20 ceu)

TYPE OF ACTIVITY: Knowledge

Media: Internet

Estimated time to complete activity:
Estimated time to complete this activity is 120 minutes.

Published: March 1, 2009

Expires: March 31, 2011

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Postgraduate Healthcare Education, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s).™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

Published: March 1, 2009
Expires: March 31, 2010

PROCEDURE
Please complete the posttest questions and program evaluation online at: www.powerpak.com (a username and password are required to access your account). Upon passing the exam with a score of 70% or better, you can print out your statement of credit immediately. You can also view your test history at any time and print out duplicate statements from the Web site.

Exam processing inquiries and other inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696

TARGET AUDIENCE
This activity has been designed to meet the educational needs of pharmacists, pharmacy technicians, physicians, physician assistants, and nurse practitioners.

GOAL
The goal of this educational activity is to educate health care professionals about the issues associated with maintaining proper vigilance regarding pain medications, with emphasis on controlled substances for pain, and provide strategies for continued awareness of drug diversion.

EDUCATIONAL OBJECTIVES
After completing this activity, participants will be able to:

1. Identify the problem of undertreated and untreated pain in the United States;*
2. List the Federation of State Medical Boards suggestions for the treatment of pain with opioids;*
3. Describe the assessment of the risk of controlled substance diversion in the provision of opioids to treat pain;*
4. List the factors that are predictive of aberrant drug-related behaviors by patients with pain;* and
5. Describe the VIGIL process as a systematic method to manage drug diversion while treating pain with opioids.

*Also applies to pharmacy technicians

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Postgraduate Healthcare Education (PHE), and Purdue Pharma L.P. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, PHE, and Purdue Pharma L.P. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.